4.5 Review

Postoperative adjuvant radiation for cervix cancer: reflections on the evidence and a peep into the future

期刊

出版社

BMJ PUBLISHING GROUP
DOI: 10.1136/ijgc-2021-002528

关键词

cervical cancer; radiation; brachytherapy

向作者/读者索取更多资源

This article reviews the treatment strategies for early stage cervical cancer and highlights the latest advances in radiation technology and risk stratification research. These developments not only reduce treatment-related adverse events but also provide opportunities to re-evaluate the therapeutic ratio and further develop postoperative risk stratification.
Early stage cervical cancer, stages IB1-2 and IIA1, can be treated with (chemo)radiation and brachytherapy or radical hysterectomy with or without further adjuvant (chemo)radiation. In a carefully selected cohort for surgery, traditionally a small proportion of patients would need adjuvant (chemo)radiation so that the therapeutic ratio is maximized. However, advances in radiation technology, specifically intensity modulated radiotherapy, have led to a reduction in treatment related adverse events. Also, recent developments in risk stratification suggest using a lower threshold to offer adjuvant treatment to minimize pelvic relapse. These developments together present opportunities of not only re-examining the therapeutic ratio but also of further evolving postoperative risk stratification. This review article summarizes the current evidence on adjuvant treatment strategies and summarizes the key areas where research should be focused.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据